Ignite Creation Date:
2024-05-06 @ 3:43 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02359201
Status:
COMPLETED
Last Update Posted:
2015-04-21
First Post:
2015-02-04
Brief Title:
Assessment of V0018 15 mg Effect on Craving
Sponsor:
Pierre Fabre Medicament
Organization:
Pierre Fabre Medicament
Study Overview
Official Title:
Double-blind Randomized Placebo-controlled Cross-over Study of the Effect of a 15 mg Nicotine Lozenge on Smoking Craving
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the reduction of craving after administration of V0018 15 mg compared to placebo in healthy moderately dependent smokers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2014-004424-21 | EUDRACT_NUMBER | None | None |